The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats
about
Presynaptic dopamine modulation by stimulant self-administrationStriatal signal transduction and drug addictionLack of self-administration of cocaine in dopamine D1 receptor knock-out miceDrug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviorsOpposing effects of dopamine D1- and D2-like agonists on intracranial self-stimulation in male rats.Applications of a rat multiple tissue gene expression data set.Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats.D1 dopamine receptor: a putative neurochemical and behavioral link to cocaine action.Predicting abuse potential of stimulants and other dopaminergic drugs: overview and recommendationsIn vitro reinforcement of hippocampal bursting: a search for Skinner's atoms of behaviorDopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum.The potential of dopamine agonists in drug addiction.The GSK3 signaling pathway is activated by cocaine and is critical for cocaine conditioned reward in micePsychomotor stimulation by dopamine D₁-like but not D₂-like agonists in most mouse strainsIntrastriatal dopamine D1 antagonism dampens neural plasticity in response to motor cortex lesion.Behavioral effects of the R-(+)- and S-(-)-enantiomers of the dopamine D(1)-like partial receptor agonist SKF 83959 in monkeysSelective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats.Differential Roles for Dopamine D1-Like and D2-Like Receptors in Mediating the Reinforcing Effects of Cocaine: Convergent Evidence from Pharmacological and Genetic Studies.How the epigenome contributes to the development of psychiatric disorders.Hypocretin/orexin involvement in reward and reinforcement.Attenuation of relapse to cocaine seeking by dopamine D1 receptor agonists and antagonists in non-human primates.Mu opioid receptor mRNA in nucleus accumbens is elevated following dopamine receptor activation.Cellular targets of brain reinforcement systems.High ambient temperature increases intravenous methamphetamine self-administration on fixed and progressive ratio schedules in rats.Dopamine D1 and D3 receptor interactions in cocaine reward and seeking in rats.Neural substrates of drug craving and relapse in drug addiction.Dopamine D1-Like Receptor Agonist and D2-Like Receptor Antagonist (-)-Stepholidine Reduces Reinstatement of Drug-Seeking Behavior for 3,4-Methylenedioxypyrovalerone (MDPV) in Rats.
P2860
Q26823507-8FC9E585-CD1B-405A-8390-0D2776E41A3CQ28392093-D894DDB3-2872-4429-B446-C9226A84BD16Q28511866-C39DE548-6907-4583-A44E-DFAEB3C3BBF9Q30490304-DE7FAEB1-6305-4CD3-B5DB-7D1C19C4DDD4Q30764851-50B9F468-060D-4564-9478-3E632D93CB46Q33200797-2171983D-26B7-43C9-82C2-3BE7CDEF0574Q34065808-8B62B35A-8930-4EA4-B072-E78A5D82A03DQ34121024-D0D3C8B8-7D9B-4356-8A5D-79A639492DD3Q34225896-E2909F5A-5BBB-4A2C-B271-CF51DA31CCAAQ34270042-6AE617DA-0A35-4E99-8E12-EAD910BB735EQ34383670-1AD68534-2C40-4A39-A555-DA9D9EEB59CBQ34581491-6D6242EC-23A0-4769-9ED1-78143751A34CQ35088414-78227B6F-B802-4E6A-A253-40F4EAB57E06Q35870180-AC8587EF-3CE5-4CE3-82A8-D73DCC3B0409Q35955621-9D7719C4-0D56-4A7F-ACD9-7A258E215CACQ36749491-E539F2D7-3AEB-4EBD-9DBF-3A73714DD846Q37052512-3892F228-8F22-49C1-8D29-C09A769F8E1FQ37064869-1AD865F0-32F0-42AE-B469-CF5C51CE725FQ37686429-3BC10C96-E310-4CA5-88E4-D37F5D43CD7BQ38013859-BDCC62B8-1544-44EA-90C5-07721F38EAEEQ44329434-EE20FB00-53A2-474E-9A98-D11FF6B425D0Q44344394-1B3F0EA1-E4A8-44D5-92A9-0E4B8FA9AF5DQ46781453-D9327986-8806-4CC4-9747-EEE424C049A7Q46813771-51DE5438-766C-4055-9B8A-EB24828FAC29Q47393187-84BB6877-8F9F-4452-8E06-C5937859332CQ48369649-C1AE07F2-119F-4C9C-B0F0-2905EDD07137Q52621335-F80126F3-E0D5-42B8-804D-17458ECF7C1D
P2860
The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats
@ast
The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats
@en
The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats
@nl
type
label
The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats
@ast
The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats
@en
The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats
@nl
prefLabel
The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats
@ast
The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats
@en
The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats
@nl
P1433
P1476
The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats
@en
P2093
P304
P356
10.1016/0006-8993(92)90155-3
P407
P577
1992-06-12T00:00:00Z